PRO-2000 exhibits SARS-CoV-2 antiviral activity by interfering with spike-heparin binding.
Vanderlinden E, Boonen A, Noppen S, Schoofs G, Imbrechts M, Geukens N, Snoeck R, Stevaert A, Naesens L, Andrei G, Schols D.
Vanderlinden E, et al. Among authors: schols d.
Antiviral Res. 2023 Sep;217:105700. doi: 10.1016/j.antiviral.2023.105700. Epub 2023 Aug 9.
Antiviral Res. 2023.
PMID: 37562608
Free article.